Redox Podcast_HIMSS22: Audio automatically transcribed by Sonix

Redox Podcast_HIMSS22: this mp3 audio file was automatically transcribed by Sonix with the best speech-to-text algorithms. This transcript may contain errors.

Niko Skievaski:
Welcome to the Redox podcast, where we explore the intersection of healthcare and technology with some of our industry’s most notable contributors. I’m your host, Niko Skievaski. In my day job, I’m the co-founder and president of Redox, where we’re on a mission to enable the frictionless adoption of technology and healthcare. We started the show to share what we’re learning and hopefully allow you to skip some steps as you embark on your journey through making healthcare a little bit better. So without further ado, I welcome you to the Redox podcast.

Niko Skievaski:
Holy cow, we’re really going to HIMSS, it’s almost a surreal feeling I got to pull out the suits and dust off my dress shoes just like old times. On today’s show, I catch up with two Redoxters who I’ve been going to HIMSS with for years, we have Nick Hatt, one of our first engineers and general thought leader in the interoperability space, I also connect with Matt Ripkey from our partnerships team, who’s been wrangling the Big Tech players in our space. And we discuss what we think HIMSS will be like this year, as well as priming for some of the reduction … in store. As a preview Redox can be found on the show floor at the Hefti booth number 2621, our booth will have a stage where we’ll showcase our customers, partners, and our product team to discuss the latest in interoperability, and we’ll also be doing a few live podcast recordings from the stage, a little bit nervous about that, should be fun, and in true Redox fashion, we’ll also be throwing a party on Wednesday night at Taverna Opa, find all of the details at RedoxEngine.com/HIMSS22. Ok, let’s get into it!

Nick Hatt:
Hey Niko!

Niko Skievaski:
Hello, Mr. Nick Hatt. So do you know how many HIMSS you’ve been to?

Nick Hatt:
I’d say five or six or so? I remember one of the first ones where we actually had a booth was, I think the first one ever was a 10 by 10 booth or like really felt like 8 by 8 and just a big printed out vinyl Redox logo.

Niko Skievaski:
Yeah.

Matt Ripkey:
Nothing special.

Niko Skievaski:
Oh, I think was that the one where we had, I had ordered this like it was like a foam floor that kind of looked like a hardwood floor?

Nick Hatt:
Yeah.

Niko Skievaski:
Yeah, that was great. That was a good year. So you’re a developer, what do you get out of HIMSS? Like, what do you like going for? Do you go to the sessions? Do you hang out and talk to people? Do you visit other booths?

Nick Hatt:
No. I mean, I think I just like to get insights in what customers are thinking or prospects, and it’s just kind of those random interactions as people come through the booth and you can sort of have a kind of conversation you’d have, like on a phone call or, that you don’t necessarily get right away, right? Like it’s just there, there’s this chance interaction that’s special. And then it’s nice to have more technical people like, obviously, we’re an API company, so it’s pretty technical, and then if you get the right technical people at HIMSS, someone can kind of pull you into a conversation and then you raise the credibility of Redox by just kind of being able to speak to all the specific details. A lot of times, if you get somebody like that coming into the booth, they have like one really specific problem that they’re thinking about, and it’s probably something that they have like within the last two weeks, right? And to be able to speak to their pain is pretty powerful, so happy to help out in that regard.

Niko Skievaski:
And do you like going?

Nick Hatt:
Generally, yeah! I mean, I think I prefer Vegas like a thousand times to one, but.

Niko Skievaski:
Why is that?

Nick Hatt:
It’s, just you know, Orlando, don’t get a chance to take big part in the fun, but Vegas, it’s all right there. So yeah, Orlando is more just getting to one of the four convention centers, that is the right one, and going to the party and then just crashing, so.

Niko Skievaski:
Nice, yeah, so neither of us went to HIMSS last year, the HIMSS21, but we had some Redoxers there. And then of course, HIMSS20, was the canceled HIMSS, the whole debacle with the pandemic, you know, that whole thing. Do you think that conferences are back? Like, of course, HIMSS is the biggest one out there, but we’re kind of in this time where big is it necessarily better? What’s your feeling on that?

Nick Hatt:
Yeah, it’s going to be a real vibe check. I mean, I don’t have too much insight other than there are now, like competing conferences and stuff like that. I think a lot of people on the internet have speculated about like is this whole COVID pause going to be the death of HIMSS, so I’m just kind of going to go and look and see and evaluate for myself. I think, you know, maybe the contrarian thing is just like people have been cooped up so long that conferences are going to be back even if they’re not, that’s the most useful. And, you know, it’s definitely like from folks I’ve talked to on our customer side, people say they want to go, but they’re not going this year, so it could be a weird vibe this year and next year it’s back. So just kind of wait and see.

Niko Skievaski:
Yeah, yeah. If you had to give us a guess of what you think it’s going to be like this year, yeah, what would your hypothesis be?

Nick Hatt:
Yeah, I mean, I think, I think probably just lighter traffic and it kind of feels the same and the booths are the same, and the sort of like, you know, overall, just like size and scope is the same, but it’s going to feel less intense maybe, there’ll be some downtime. So I have no insider information about like, you know, number of people registered or anything like that, and it could all depend too on just kind of who’s going hard at the party on Monday night and who’s going hard at the parties on Tuesday night. So what they managed to make it to the floor, those other days.

Niko Skievaski:
Yeah, yeah. I remember, you know, of HIMSS past, HIMSS19, and before the trade show floor was just shoulder to shoulder with people, it was packed, packed in a way that I can’t imagine being in again because I haven’t been in a crowd like that for years. So, yeah, if it’s anything like that, it’ll certainly be a surreal feeling being back with that many people. So you mentioned parties, what’s funny is my first HIMSS was with, I can’t remember what year it was, but it was with Epic and I was a booth babe, I hung out at the booth, talk to customers, prospects, it was really fun, and then I went to dinner with some of my Epic friends and then went to sleep and then my first year going with Redox, I discovered these parties that happen and was like, there’s this whole world of HIMSS I had no idea existed. Yeah, what’s going on in the party space?

Nick Hatt:
Yeah, honestly, I look to some of the younger members of the Redox team for that guidance and know, just try to act cool. The times have definitely changed. You know, like Athena used to have a crazy party that was really, really like Universal Studios or like that kind of thing and blew off all the doors. And now they’ve been sort of sold and bought four times since then. So, yeah, you know, it’s definitely kind of something I don’t really think about till I’m there, but definitely a good place to network and sort of meet people and have those conversations again, just got to make sure you stay hydrated and get enough sleep, but I’m always, you know, I never lost the love of free food and drink from, I guess, my college days, so I’m looking out for them.

Niko Skievaski:
Yeah, yeah. So I’m always nostalgic thinking about the days of Athena’s parties. And, you know, Jonathan Busch dressed up like some character, and yeah, those were, those were fun times. Talk to me about Redox parties you’ve been to many of them.

Nick Hatt:
Yeah.

Niko Skievaski:
What’s that vibe like?

Nick Hatt:
I think the thing that is really cool about Redox parties is that our customers are so diverse, savvy, on the cutting edge, you can really have a lot of interesting conversations. I know this is going to, this probably all sounds like really cheesy, but I actually do believe that, you know, sort of being an API company and having such a broad base of different workflows and verticals we cover, you kind of get really interesting people in the room and the people who really want to come talk to Redox or technical-minded and are usually doing pretty cool things in healthcare, so that’s one reason, that’s probably the main reason to go in and of itself. And then, yeah, just the, Niko, you’ve been involved in planning all the parties and done a great job. You have great taste, so everything from the vibe to the venue, the food, the Redox, Redoxaritas, the margaritas is usually very on point, so.

Niko Skievaski:
Is it margaredox or redoxarita?

Nick Hatt:
Yeah, good thing to beat.

Niko Skievaski:
Wow. I think I was just, I had a little anchoring bias there because, I saw a slide that called it a Redoxarita, maybe it was Redox-sangria or something like that. Still not clear, but margaredox is actually, like, kind of rolls off the tongue better.

Nick Hatt:
Yeah, I did see that to our, our registration this year has Redoxarea, which I don’t think that’s ever what it was called. But our marketing team has gone rogue and they’re making up drink names just like we did back in the day, I love it.

Niko Skievaski:
Yeah, I was a little worried about that at Redox-area is kind of what you get the night after the day after the party, if you, if you go too hard. So it is a healthcare conference, after all, so.

Nick Hatt:
Oh my gosh, now I feel an urgency to change it. That’s funny.

Niko Skievaski:
As long as we don’t call it Skievaski’s revenge. Yeah, so what are you most excited about? You’re going to be hopping on a plane in a couple of weeks, what are you pumped about?

Nick Hatt:
Well, I think our, our booth and our swag is going to be really exciting to see. We had a huge booth in 2019, sort of the last real HIMSS, and that was awesome. People just like to come up and compliment us and sort of say, like, hey, Redox, you guys really come a long way, so it’s just to see what? It’s crazy three years later, we’re still here, we’re doing great, I don’t know, I like compliments. But yeah, and I think, I think just that energy is going to be really exciting, it’s, definitely drains you. But talking to everybody there just kind of resets everything, kind of makes you more motivated to kind of get whatever stuff you’ve been thinking about, to just kind of try it out and sort of get it out there. So, yeah, just excited for the sort of energy boost I get from it.

Niko Skievaski:
Very cool. Well, I’m pumped to hang out with you there, should be fun.

Nick Hatt:
Yeah. Likewise, then I’ll be, I’ll be speaking at the Redox booth, if not multiple times, at least once, so, yeah.

Niko Skievaski:
Three, yeah, I forgot we have a stage at our booth this year and so we’ll have some customers come, we’ll have some experts like yourself speak, what are you speaking about? Do you know? You can make it up?

Nick Hatt:
Yeah, I think I’m just going to kind of highlight our Fire strategy and sort of what that’s going to mean for developers and how you can build against Redox moving forward. So, it’s going to be a bigger picture talk, but hopefully fill in some of the questions that people might have about what Redox is doing with Fire.

Niko Skievaski:
Yeah, well, isn’t it like I could use Fire or I could use Redox?

Nick Hatt:
It is, yeah. And I think we’re, not to spoil to talk too much, we’re saying that it can be both and you can choose. We’re definitely seeing groups who come in and want to only use Fire, and in some ways that makes sense for their the way they want to design their product and their architecture, so we’re more than happy to support that.

Niko Skievaski:
Sweet, we’ll pump it to check it out. Yeah. And obviously, you know, Fire’s had a, the Fire has spread to use a terrible Fire pun, over the past decade or so, and it is cool to see that because we need some commonality there. I love that we are enabling developers to not have to make that choice and can support a standard while also having the scalability of a system like Redox.

Nick Hatt:
Yeah, for sure. And I’m the tech lead for the payer squad at Redox and we have a lot of exciting payer offerings in Fire only. So we’re following sort of the regulatory path that’s been set forth and kind of offering the X12 to Fire translation as a service, so.

Niko Skievaski:
Nice!

Nick Hatt:
It’s going to be pretty exciting to get feedback on.

Niko Skievaski:
Tell me a little bit more about that, what does the payer want an X12 to Fire translation?

Nick Hatt:
Yeah, I think there’s, there’s a few different use cases. The first is there are just kind of federal rules pushing Fire usage or proposing …. now, that’s in the prior off space. There’s this really tricky part of the current state, which is like X12, this other standard is written into law, so it’s part of HIPAA that you have to use X12. But as the sort of rules are interpreted and the law is written, the X12 just has to be one hop. So you can basically, like put something in front of the X12, up, convert it to Fire and then have something that’s nicer for your developers to use and still kind of be following the rules and having X12 kind of go across the boundary. So yeah, it’s definitely like a bit of, this is probably happening for real from the government perspective. And then just developer efficiency, making internal developer’s lives easier and just kind of letting them work with the modern standard like Fire.

Niko Skievaski:
Are you going to give a talk about a payer sort of workflows and stuff like that? It seems like another good topic to.

Nick Hatt:
Yeah, I think that would, that would probably be the second one. Still, kind of, we definitely love to highlight our customer stories, and the things that I think our customers do are one hundred times more compelling than anything I could kind of get up there and spit, so I’m happy to give up a slot for a customers to speak, and we’re just kind of finalizing that schedule at the booth. So, yeah.

Niko Skievaski:
Very cool. Awesome. Well, if someone out there is listening to this and they want to hang out with you at HIMSS, how can they find you?

Nick Hatt:
Well, yeah, definitely just pop by the booth and I plan to be there both days. And if you can’t find me, I probably was just pulled away for one of those conversations that I love so much. So just talk to anybody from Redox and we’re a small company and they’ll be able to find me so.

Niko Skievaski:
Nice, nice. Are you going to be rocking your signature Hawaiian shirts?

Nick Hatt:
Probably. I mean, I think that I’ve been thinking a lot about my wardrobe and kind of wonder if, like the start-up t-shirt under a blazer is still the way to go, so just let’s, let that be a surprise for those who attend in-person.

Niko Skievaski:
Awesome. Well, cool, thanks for, thanks for chatting with me about HIMSS. And yeah, like I said, I’m super pumped to hang out with you there.

Nick Hatt:
Thanks, Niko.

Niko Skievaski:
So today I have a HIMSS veteran who’s been with Redox since as long as I can remember. Matt Ripkey, who are you? What do you do at Redox? And let’s get into this.

Matt Ripkey:
Hey, Niko! Yeah. Long-time listener, first-time caller. My name, Matt, I am a director on our strategic partnership team over at Redox, but have quite a bunch of different roles, I spend a lot of my time figuring out how to connect providers to the technologies that they use every day and figuring out ways to build scalable integration strategies for some of the biggest funders in healthcare. So pretty cool opportunity, it’s been a very fun ride at Redox for the last six-plus years, and yeah, I haven’t been at HIMSS since 2019, was super pumped to go in 2020, and then the world collapsed in on itself.

Niko Skievaski:
Did you go last year?

Matt Ripkey:
I didn’t. I think we were all kind of getting set to go, but yeah, then it, if my memory serves correctly, it’s been probably, yeah, at least since 2019.

Niko Skievaski:
Last year we had a Mexican restaurant and a bunch of our salespeople were there.

Matt Ripkey:
I didn’t go.

Niko Skievaski:
Yeah, I didn’t go either. But yeah, we had a party and we had a, we didn’t have a booth, but we just had people, we had a restaurant for like the whole week.

Matt Ripkey:
Yeah, you know, last year we went boothless and tried our hand at just setting up a party outside and being around. I think it actually turned out pretty solid, if I remember correctly, we got just about as many people to the party as we normally see, or at least pandemic adjusted for the attendance. I actually had a bunch of people reach out afterwards and say, like, hey, how did the booth move go? And we broke down, you know, like the return on the marketing dollars and the rest of it was as successful as it could be for limited attendance and limited Redox availability. So it takes a while to get everybody back, been too long, it’s fun to get in-person with everybody, you know, people kind of either love or hate conferences. I know you and I probably lean towards the, we like going to them. Yeah, it’ll be fun to be back around everybody, to be funded, you have the world-famous Redox party back, and I’m really excited to get down to Florida, especially coming from the Chicago winter here, ready to warm up a little bit.

Niko Skievaski:
Nice. Nice. Yeah, it’s interesting because yeah, we did have a good conference last year without having a booth, you know, still had great meetings at the restaurant, but this year we’re going big like we got a huge booth I was looking at the, the plans for marketing, I was like, seriously? That thing is crazy!

Matt Ripkey:
I remember our first HIMSS, we had like a little lean two in the interoperability ghetto. And yeah, so we’ve come a long way. And the first time that you and I went to HIMSS together, we flew down maybe Saturday morning, the event ready to start on Monday, and I remember that you and I rolled out our little foam board floor and like two or three camping chairs and everybody else was setting up multimillion-dollar booths, wo a little bit more fun, you know, with the startup and with the Redox history and trajectory, HIMSS feels like kind of a measuring stick on the wall. You know, every year you get to go and make sure that you’re a little bit taller than the year before, so it’ll be fun to finally have a big booth. You know, I think there’s, at least a few dozen Redoxers going, and obviously, we have to reestablish the bar for what a very successful Redox party looks like, so.

Niko Skievaski:
Yeah, you know, it’s interesting because HIMSS is like, if I think back, it’s shoulder-to-shoulder human beings smashed into a conference center, and I honestly haven’t been in a crowd like that in years. Do you think there’s going to be a ton of people there or like, what’s your sense on who’s going to show up?

Matt Ripkey:
Yeah, I mean, you know, I think the last few years, even if you’re not doing healthcare conferences, conferences in general have obviously been struggling a little bit, you know, being a healthcare-specific group and a lot of providers and you know, folks that are actual doctors, first responders, nurses, et cetera, being on the floor, you know, we’ll see. I think we’re in a place where most everybody is that’ll be there is, you know, they’re vaccinated, they’re proving that they’re testing, they’re embracing different risk trade-offs in their own risk calculus. And so hopefully the floor is back to being somewhat full and the folks that are there are excited to be there and the nerves are kind of gone. I know cases are way down everywhere, so hopefully, we’ve kind of turned a corner and we can get back to cram and shoulder-to.shoulder onto a conference floor.

Niko Skievaski:
Yeah. And you know, it’s funny, like leading up to when the pandemic started, and of course, conferences became difficult, HIMSS was already feeling some pressure for some new entrants on the scene, right? We had the HLTH conference, as I affectionately refer to it as, the HLTH, I’m trying to make it stick, it has, hasn’t been working yet, though. And then, of course, now we have ViVE, which is next week as of this recording, which Redox isn’t going to have a big presence at because we kind of went all-in on HIMSS, but you’re going to be there.

Matt Ripkey:
Yeah.

Niko Skievaski:
Why are you going to ViVE?

Matt Ripkey:
Yeah, we’re going to go Lone Ranger, skeleton crew or the few, the proud, the Redox. I wanted to go check it out. I think HIMSS is traditionally geared towards the vendors in the booth, selling to the health system employees walking floor, right? And as a company that serves mainly digital health vendors on behalf of their provider customers. We did a lot of work selling booth-to-booth in the early days, walking around and making sure each booth knew about Redox.

Niko Skievaski:
Yeah, it was our door-to-door sales strategy.

Matt Ripkey:
That’s right, yeah, I do remember distinctly you telling me, you have one hundred and fifty business cards in your hand and I don’t want you to have any left when you come back. I think ViVE is much more geared towards the digital health vendors themselves, so it’ll be interesting just to see how that plays out and what that dynamic looks like. It seems to be a little bit more focused on the health tech and the different apps and vendors that are, that are going to be there, versus every vendor trying to sell to every doctor that walks by their booth.

Niko Skievaski:
Interesting.

Matt Ripkey:
Going to be down in Miami Beach, which, you know, if you’re going to try to make a competitive location, Miami Beach, a pretty cool place to go. And yeah, I’m going to end up actually going to both, which means back-to-back weeks in Florida and hopefully a little bit of a suntan.

Niko Skievaski:
Are you going to stay the weekend?

Matt Ripkey:
I am. Yeah, I’m going to end upk, I’ve actually got some family down there right now. So when I go to ViVE, I’m going to go hang out with my family for a few days and I’m going to drive up to Orlando.

Niko Skievaski:
Nice.

Matt Ripkey:
And hopefully, I can find a way to press my shirts and make sure my sport coats are clean between now and then.

Niko Skievaski:
Yeah, I wonder if that was kind of the ViVE strategy like, you know, they know they’re competing with HIMSS, they don’t want to necessarily directly compete with HIMSS on the same week. Yeah, I wonder if people are going to just stick around, I know a lot of people have kids and family and stuff and can’t make that work. Have you heard of other people that are doing both conferences because I hear one or the other?

Matt Ripkey:
I’ve heard a few, a lot of folks are doing one or the other. I know that there are companies that are going to both that are sending employees to kind of one or the other. But yeah, one of the benefits of having a little flexibility of not having kids yet is I can go down and spend two weeks back-to-back conferences. So if you see me by the last day of HIMSS and I am just kind of sick of shaking hands and walking on my feet, you know where I’m coming from.

Niko Skievaski:
So we haven’t been to conferences in a while, what are you most excited about heading into two in a row now?

Matt Ripkey:
You know, I, I’m really excited to see some old friends and to see some folks, you know that you just don’t run into, you know, over the last two years, there are people that just haven’t seen that I’m excited to rub shoulders with again. I am really excited that, you know, to do that measuring stick act with Redox and kind of see how we line up and how we look after two years of not having a booth, making our triumphant return to the floor. I mean, I am tremendously excited about the Redox party, and if you’re listening to this and you have an RSVP yet, go do that because it will sell out, and I don’t want to be out front with you begging me, Matt, can you get me in the door? And so that’ll be, that’ll be a good time. So yeah, I’m excited to see everybody. One of the things I’m kind of looking forward to when this whole thing set off in 2019, there was a little bit of effort from some of the big tech companies and the cloud providers starting to make their entrance into healthcare, but it was still, you know, the floor was dominated by the EHR vendors, right? And, you know, now 2022, a lot of dynamics have shifted there. And you know, the big tech vendors have proven that they have some footholds in healthcare and that the cloud is being embraced by the provider community. So it should be fun to see those booths, you know, really kind of come to life and have something to actually talk about and some value to show to the audience and excited to see what they come up with.

Niko Skievaski:
Yeah, yeah. I think that’s a, that’s an interesting place we can go obviously with, with your role at Redox, working with a lot of the big tech players out there, not the, not that we should name names necessarily, but like what are some examples of ways that they’re actually engaging with health systems? Because I think you’re right like back at the last times, it was kind of a hypothesis, they’re like, we have the cloud, maybe you need the cloud, but like, have they shown that that’s the case?

Matt Ripkey:
Yeah, I think one of the things that I keep a really close eye on, if you think of the digital health ecosystem, the EHRs, and represented the database on which the stack was built for providers for a very long time, right? And most of it was on PREM systems and custom integrations and really building out workflows and tools to suit their particular health systems needs. And that works great for the health system, in some cases, it can be tedious and expensive. But now that they’re embracing more kind of cloud architectures and using the cloud as the basis of their technology stacks, it really opens up a lot of things because those vendors are particularly good at building and curating developer communities and making tools easy to build for startups and really kind of democratizing access to who can build what tooling. And so one of the things that we watch is what is the shift in the gravity look like as it goes from the EHR, as the center of the tech stack to a cloud database and a fire store as the center of a tech stack? And there are multiple examples of that, you know, Amazon has health like, Microsoft as cloud for healthcare, Google has a pretty significant cloud for healthcare as well and runs all sorts of different fire store products on top of that. Each of them have their own different commercial thrusts, each of them have their own different value props, but we are seeing that they’re gaining adoption, right? Every year we see more and more health systems embrace the cloud, and what I hope that allows for is easier, scaled integrations, and more forthright marketplace experiences for vendors. You look at how some of the EHRs have embraced third-party apps, it’s not exactly great, and I think the big tech vendors come at it from a perspective of, look, we actually can’t do this alone, and we’re not going to build all that functionality, come play with us and play on our cloud. So that should be fun to watch, I’m excited to see kind of how those vendors have matured, what their success stories look like. But yeah, they’re here, they’re staying here, and if you need to get your RHR data to any of them, give me a call.

Niko Skievaski:
I think I want to do another show where we just go on down on that topic because it’s quite interesting, and I think there’s a lot, there’s a lot of stories we can probably share about that work that we’re doing there already. So, maybe we should do that.

Matt Ripkey:
Yeah, I’m happy to make a return to the Redbox Pod, we can figure that out, and spend all sorts of time talking to you about the embrace of the cloud.

Niko Skievaski:
Nice. Well, I have probably the most important question for you, and it’s quite personal, I started growing this moment because I was like, I’m not going to conferences anymore, do I cut the mullet for HIMSS?

Matt Ripkey:
Listen, I, I’ve known you for a long time and you got to just be you, man, I think, you know, nobody wants to see a clean-shaven, clean-cut, tucked up Niko wearing a tie. So I say, let the mullet ride.

Niko Skievaski:
Let it ride.

Matt Ripkey:
Let it ride, if you want to maybe shave an R or an up carrot into the side, maybe that’s something you consider. But otherwise, yeah, no, leave it all on red, let it ride, baby.

Niko Skievaski:
Great, great. I’m into it. Cool. Well, I’m so pumped to hang out with you in a couple of weeks at HIMSS, have a great time at ViVE. Yeah, stay healthy while you’re doing this too, because it can be a lot to be shaking this many hands.

Matt Ripkey:
Well, you got to remember for those of you who haven’t been to your conferences for a while, hydrate, hydrate, hydrate and never stop drinking water, you know, make sure you wear your sunscreen when you’re outside, all the rest of it, keep your hands clean.

Niko Skievaski:
Yeah.

Matt Ripkey:
Maybe a little too much, you know?

Niko Skievaski:
Yeah.

Matt Ripkey:
Other than that, I’m, I’m just excited to be around everybody again. It’ll be great to have everybody back in one place and get to see kind of the whole industry and where we stack up now.

Niko Skievaski:
For sure, nice. Awesome. Well, thanks for joining me, Matt.

Matt Ripkey:
All right, Niko. Thanks, man.

Niko Skievaski:
And there you have it. Thanks so much for listening to the Redox Podcast. Once again, check out RedoxEngine.com/HIMSS22 to find us at the event. I cannot wait to connect with you all in person in Orlando.